ArticleFrontiers in oncology2026

Preoperative serum HE4 combined with CA125 testing for predicting the risk of suboptimal cytoreduction in advanced epithelial ovarian cancer.

Chun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.